EVALUATION OF A BASAL BOLUS INSULIN PROTOCOL FOR CONTINUING DOSING EFFICACY AND SAFETY OPTIMIZATION

被引：0
|
作者：
Greene, Maureen [1 ]
机构：
[1] Wheaton Franciscan Healthcare St Joseph, Milwaukee, WI USA
来源：
CRITICAL CARE MEDICINE | 2014年 / 42卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
334
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation
    Villani, Alessia
    Scalvenzi, Massimiliano
    Micali, Giuseppe
    Lacarrubba, Francesco
    Genco, Lucia
    Ruggiero, Angelo
    Fornaro, Luigi
    Guerrasio, Gianluca
    Potestio, Luca
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (07) : 525 - 531
  • [42] EARLY COMBINATION EFFICACY OF VILDAGLIPTIN IN BASAL-BOLUS INSULIN THERAPY WITH METFORMIN: RANDOMIZED CROSSOVER STUDY
    Takeishi, S.
    Tsuboi, H.
    Takekoshi, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 : A57 - A57
  • [43] Safety and Efficacy of a Novel Basal-Bolus Insulin Delivery Device (IDD) in Adults with T2D Using Rapid-Acting or Regular Human Insulin
    Aronson, Ronnie
    Mahoney, Edward T.
    Saliu, Drilon
    Bergquist, Leya
    Hirsch, Laurence
    DIABETES, 2019, 68
  • [44] Efficacy and Safety of Insulin Degludec/Insulin Aspart Compared with a Conventional Premixed Insulin or Basal Insulin: A Meta-Analysis
    Moon, Shinje
    Chung, Hye-Soo
    Kim, Yoon-Jung
    Yu, Jae-Myung
    Jeong, Woo-Ju
    Park, Jiwon
    Oh, Chang-Myung
    METABOLITES, 2021, 11 (09)
  • [45] Efficacy and safety of insulin glulisine (GLU) vs insulin lispro (LIS) as part of a basal-bolus insulin (INS) regimen in children and adolescents with type 1 diabetes (T1DM)
    Philotheou, Areti
    Arslanian, Silva
    Blatniczky, Laszlo
    Peterkova, Valentina
    Souhami, Elisabeth
    Danne, Thomas
    DIABETES, 2008, 57 : A496 - A497
  • [46] Efficacy and safety of an insulin infusion protocol during and after cardiac surgery
    Studer, C.
    Sankou, W.
    Penfornis, A.
    Pill-Floury, S.
    Puyraveau, M.
    Cordier, A.
    Etievent, J. -P.
    Samain, E.
    DIABETES & METABOLISM, 2010, 36 (01) : 71 - 78
  • [47] Efficacy and safety of a dynamic computarized insulin protocol in critical ill patients
    Vaquerizo, Clara
    Alvarez, Joaquin
    Escriba, Almudena
    Velayos, Carlos
    Alonso, Angela
    Sanchez, Susana
    Saldana, Teresa
    Pardo, Candido
    Garcia, Enrique Garcia
    CRITICAL CARE MEDICINE, 2007, 35 (12) : A138 - A138
  • [48] Sliding Scale Insulin vs Basal-Bolus Insulin Therapy in Long-Term Care: A 21-Day Randomized Controlled Trial Comparing Efficacy, Safety and Feasibility
    Dharmarajan, Thiruvinvamalai S.
    Mahajan, Dheeraj
    Zambrano, Annie
    Agarwal, Bikash
    Fischer, Rachel
    Sheikh, Zahra
    Skokowska-Lebelt, Anna
    Patel, Meenakshi
    Wester, Rebecca
    Madireddy, Naga P.
    Pandya, Naushira
    Baralatei, Florence T.
    Vance, Jackie
    Norkus, Edward P.
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2016, 17 (03) : 206 - 213
  • [49] Safety and efficacy of insulin degludec/insulin aspart with bolus mealtime insulin aspart compared with standard basal-bolus treatment in people with Type 1 diabetes: 1-year results from a randomized clinical trial (BOOST® T1)
    Hirsch, I. B.
    Franek, E.
    Mersebach, H.
    Bardtrum, L.
    Hermansen, K.
    DIABETIC MEDICINE, 2017, 34 (02) : 167 - 173
  • [50] Efficacy of Insulin Degludec as Basal-Bolus Therapy After Switching from Insulin Glargine or Insulin Detemir in Young Persons with Type 1 Diabetes
    Urakami, Tatsuhiko
    Habu, Masako
    Okuno, Misako
    Suzuki, Junichi
    Takahashi, Shori
    DIABETES, 2014, 63 : A323 - A323
12345